Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

MLA

Rossignol, Patrick, et al. “Impact of Eplerenone on Cardiovascular Outcomes in Heart Failure Patients with Hypokalaemia.” European Journal of Heart Failure, vol. 19, no. 6, June 2017, pp. 792–99. EBSCOhost, https://doi.org/10.1002/ejhf.688.

APA

Rossignol, P., Girerd, N., Bakris, G., Vardeny, O., Claggett, B., McMurray, J. J. V., Swedberg, K., Krum, H., van Veldhuisen, D. J., Shi, H., Spanyers, S., Vincent, J., Fay, R., Lamiral, Z., Solomon, S. D., Zannad, F., & Pitt, B. (2017). Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia. European Journal of Heart Failure, 19(6), 792–799. https://doi.org/10.1002/ejhf.688

Chicago

Rossignol, Patrick, Nicolas Girerd, George Bakris, Orly Vardeny, Brian Claggett, John J.V. McMurray, Karl Swedberg, et al. 2017. “Impact of Eplerenone on Cardiovascular Outcomes in Heart Failure Patients with Hypokalaemia.” European Journal of Heart Failure 19 (6): 792–99. doi:10.1002/ejhf.688.